Activity-Based Costing and Budget Analysis of Vedolizumab Versus Conventional Treatments in Ulcerative Colitis and Crohn’s Disease
Global and Regional Health Technology Assessment - Italy
doi 10.5301/grhta.5000258
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2017
Authors
Publisher
Aboutscience Srl